首页 | 本学科首页   官方微博 | 高级检索  
     


Clinical aspects of control in therapy with platelet inhibitors]
Authors:I N Bokarev  L V Ovcinnikova  N A Aleksandrova  E V Kabaeva  E V Marcukova  I S Kun  L I Olbinskaja
Abstract:46 patients with ischaemic heart disease were treated with Micristin (20-40 mg/kg) or a combination of Micristin and Propranolol (80-120 mg/die). The values of bleeding time, the platelet factor 4 in lysate of thrombocytes or in plasma of patients as well as the soluble fibrin monomer complexes were investigated. They showed no obvious correlation to the clinical findings.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号